Literature DB >> 2389824

Antibody response to the 43 kDa glycoprotein of Paracoccidioides brasiliensis as a marker for the evaluation of patients under treatment.

M J Giannini1, J P Bueno, M A Shikanai-Yasuda, A M Stolf, A Masuda, V Amato Neto, A W Ferreira.   

Abstract

Sera of patients with paracoccidioidomycosis contained IgG-, IgA-, and IgM-specific antibodies to a 43 kDa antigen contained in the filtrate of a culture of Paracoccidioides brasiliensis. IgG- and IgA-specific antibodies were present in all observed patients. The IgM response was more frequent in acute cases, and the mean titers of IgG- and IgM-specific antibodies were higher in the acute forms. By the fourth month of chemotherapy, there was a decay of IgG, IgA, and IgM antibody titers to this antigen in acute cases, correlating with clinical improvement. The detection of IgG and IgA antibodies and the sequential determination of antibodies to the 43 kDa glycoprotein may be useful tools for serodiagnosis and evaluation of therapeutic efficacy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2389824     DOI: 10.4269/ajtmh.1990.43.200

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  24 in total

1.  Experimental paracoccidioidomycosis in hamsters (Mesocricetus auratus): gestational interactions.

Authors:  M G Freire de Carvalho; M R Montenegro
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

2.  Anti-idiotypic antibodies in patients with different clinical forms of paracoccidioidomycosis.

Authors:  A R Souza; J L Gesztesi; G M del Negro; G Benard; J Sato; M V Santos; T B Abrahão; J D Lopes
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

3.  Improvement of the specificity of an enzyme-linked immunosorbent assay for diagnosis of paracoccidioidomycosis.

Authors:  C F Albuquerque; S H Marques da Silva; Z P Camargo
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

Review 4.  Serology of paracoccidioidomycosis.

Authors:  Zoilo Pires de Camargo
Journal:  Mycopathologia       Date:  2008 Apr-May       Impact factor: 2.574

5.  Detection of circulating Paracoccidioides brasiliensis antigen in urine of paracoccidioidomycosis patients before and during treatment.

Authors:  M A Salina; M A Shikanai-Yasuda; R P Mendes; B Barraviera; M J Mendes Giannini
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

6.  Use of monoclonal antibodies in diagnosis of paracoccidioidomycosis: new strategies for detection of circulating antigens.

Authors:  B L Gómez; J I Figueroa; A J Hamilton; B Ortiz; M A Robledo; R J Hay; A Restrepo
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

7.  Expression in bacteria of the gene encoding the gp43 antigen of paracoccidioides brasiliensis: immunological reactivity of the recombinant fusion proteins.

Authors:  Susana N Diniz; Kátia C Carvalho; Patrícia S Cisalpino; José F Silveira; Luiz R Travassos; Rosana Puccia
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

8.  Combined use of Paracoccidioides brasiliensis recombinant 27-kilodalton and purified 87-kilodalton antigens in an enzyme-linked immunosorbent assay for serodiagnosis of paracoccidioidomycosis.

Authors:  Soraya Díez; Beatriz L Gómez; Juan G McEwen; Angela Restrepo; Rod J Hay; Andrew J Hamilton
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

9.  Detection of Paracoccidioides brasiliensis gp70 circulating antigen and follow-up of patients undergoing antimycotic therapy.

Authors:  Silvia Helena Marques da Silva; Daniela de Mattos Grosso; José Daniel Lopes; Arnaldo Lopes Colombo; Maria Heloisa Souza Lima Blotta; Flávio Queiroz-Telles; Zoilo Pires de Camargo
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

10.  Use of recombinant gp43 isoforms expressed in Pichia pastoris for diagnosis of paracoccidioidomycosis.

Authors:  K C Carvalho; M C Vallejo; Z P Camargo; R Puccia
Journal:  Clin Vaccine Immunol       Date:  2008-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.